Acute Myeloid Leukemia, Pediatric Clinical Trial
Official title:
Efficacy Analysis of Comparison of CAMS-2005 Trial and CAMS-2009 Trial for Pediatric Acute Myeloid Leukemia
The investigators adopted the CAMS(Chinese Academy of Medical Sciences)-2009 trial for pediatric acute myeloid leukemia (AML) patients between 2009 to 2015, in which a risk-stratified strategy and dose-dense intensive chemotherapy were introduced. The outcomes of CAMS-2009 trial were retrospectively analyzed, and compared to the CAMS-2005 trial.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06158828 -
Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML
|
Phase 1/Phase 2 | |
Recruiting |
NCT04678336 -
CD123 Redirected T Cells for AML in Pediatric Subjects
|
Phase 1 |